Comparison study of Beninese and Chinese herbal medicines in treating COVID-19.

Authors:
Houeze EA; Wang Y; Zhou Q; Zhang H; Wang X.

Journal:
J Ethnopharmacol

Publication Year: 2023

DOI:
10.1016/j.jep.2023.116172

PMCID:
PMC9911150

PMID:
36773790

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Ethnopharmacol

Abbreviation: J Ethnopharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Social Sciences

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Chemical profiling and unraveling of anti-COVID-19 biomarkers of red sage (Lantana camara L.) culti…
Darwish RS; El-Banna AA; Ghareeb DA and 3 more (2022) - Transparency Score: 2/6
Efficacy and safety of add-on Viola odorata L. in the treatment of COVID-19: A randomized double-bl…
Adel Mehraban MS; Shirzad M; Mohammad Taghizadeh Kashani L and 5 more (2022) - Transparency Score: 4/6
Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhib…
Zhu Y; Han Q; Wang L and 10 more (2022) - Transparency Score: 4/6
Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB …
Cai J; Wang YL; Sheng XD and 2 more (2022) - Transparency Score: 3/6
Therapeutic and palliative role of a Unani herbal decoction in COVID-19 and similar respiratory vir…
Fazil M; Nikhat S. (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability data will be made available on request. acknowledgements this work was supported by the (no: 82141213); (no: zyycxtd-c-202009"

Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors have no conflicts of interest to declare."

Evidence found in paper:

"This work was supported by the 10.13039/501100001809National Natural Science Foundation of China (No: 82141213); Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine (No: ZYYCXTD-C-202009). The authors also express their gratitude to all the people involved in this research project from the survey to editing."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025